Partnering Deals and Alliances with Big Biotech:Industry Trends, Size and Shares Research Report

33 %
67 %
Information about Partnering Deals and Alliances with Big Biotech:Industry Trends, Size...
Technology

Published on March 5, 2014

Author: Mathyupol

Source: slideshare.net

Description

Partnering Deals and Alliances with Big Biotech:Industry Trends, Size and Shares Research Report
@ http://www.researchmoz.us/partnering-deals-and-alliances-with-big-biotech-report.html

Partnering Deals and Alliances with Big Biotech The Partnering Deals and Alliances with Big Biotech report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies. Partnering Deals and Alliances with Big Biotech provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big biotech companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeutic area Comprehensive access to over 1,500 partnering deals as recorded at Current Agreement, together with contract documents if available Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents Understand the key deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies The Partnering Deals and Alliances with Big Biotech report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies. This premier report provides all the information you require to better understand big biotech partnering. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. Over 300 charts allow quick understanding of each big biotech companies dealmaking trends over the last four years. This report contains over 1,500 links to online copies of actual partnering deals as recorded at Current Agreement, together with contract documents if submitted to the Securities Exchange Commission by big biotech and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. The initial chapters of this report provide an orientation of big biotech’s dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst Chapter 2 lists the top 50 leading big biotech companies based on 2012 pharmaceutical revenues and dealmaking activity since 2009. Chapter 3 reviews the top partnering and M&A deals of 2009-2014 according to reported deal size. Chapter 4 provides a summary on best practice on how to submit an opportunity to big biotech, to ensure building of relationships and to obtain a prompt assessment and response from the business development function of the prospective partner. Chapter 5 lists forthcoming partnering events where valuable face to face meetings with big biotech provide a highly effective means of obtaining interest in novel opportunities. These events are where dealmaking gets initiated through numerous back to back meetings. The main body of the report is provided in chapter 6. In-depth profiles of every big biotech company provide everything required to assess the suitability of a company as a prospective partner. Each profile includes a company overview, partnering activity according to deal type, phase of development, therapy area and technology type. Each company profile provides a comprehensive listing of deal records available at Current Agreements, each of which links direct to an online copy of the actual deal record plus contract document if filed with the SEC. One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship. Understanding the flexibility of a prospective partners’ negiotated deals terms provides critical insight into the negotiation process in termsof what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not. This data driven report contains over 1,500 links to online copies of actual deal records at Current Agreements and contract documents, where submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. In addition, contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. In summary, the report provides the reader with the tools necessary to make successful contact with the right big biotech partners effectively and efficiently. Key benefits Partnering Deals and Alliances with Big Biotech provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big biotech companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeutic area Comprehensive access to over 1,500 partnering deals as recorded at Current Agreement, together with contract documents if available Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents Understand the key deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies Report scope Partnering Deals and Alliances with Big Biotech is intended to provide the reader with an in-depth understanding of the partnering activities of the leading fifty big biotech companies worldwide, enabling the effective assessment and selection of partners of choice, based on the latest knowledge of a company’s partnering. Partnering Deals and Alliances with Big Biotech includes: Detailed company profiles for each of the top 50 big biotech companies, including: Partnering interests and indications Partnering activity since 2009 Partner companies since 2009 Partnering activity since 2009 by: Partner company Deal type Industry sector Stage of development Technology type Therapy area Over 300 charts showing the dealmaking activity of each company since 2009 The tools to enable effective and efficient preparation for partnering negotiation with big biotech 1,500 partnering deals as recorded at Current Agreement, together with contract documents if available The leading M&A and partnering deals by value 2009-2014 The Partnering Deals and Alliances with Big Biotech report also provides comprehensive access to available contract documents for each of the fifty big biotech companies. Analyzing actual company agreements allows assessment of the following: What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subscontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2009 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeutic area Comprehensive access to over 3,000 partnering deals as recorded at Current Agreement, together with contract documents if available Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents Understand the key deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of Partnering Deals and Alliances with Big Biotech

your proposed deal terms for partner companies table Of Content executive Summary chapter 1 – Introduction chapter 2 – Big Biotech Top 50 Dealmaking Activity 2.1. Introduction 2.2. Big Biotech Partnering Over The Years 2.4. Big Biotech Partnering By Deal Type 2.6. Big Biotech Partnering By Stage Of Development 2.7. Big Biotech Partnering By Technology Type 2.8. Big Biotech Partnering By Therapy Area 2.9. Big Biotech M&a Over The Years chapter 3 – Top Big Biotech Deals By Value 3.1. Introduction 3.2. Big Bioteh Partnering 3.3. Big Biotech M&a chapter 4 – Submitting Opportunities To Big Biotech 4.1. How To Submit An Opportunity 4.2. Opportunity Submission Template 4.3. Sending Emails 4.4. Face To Face At Partnering Events 4.5. Online Submission Forms chapter 5 – Forthcoming Big Biotech Partnering Events 5.1. Forthcoming Events chapter 6 – Big Biotech Company Profiles 6.1. Introduction 6.2. Field Definitions 6.3. Company Profiles 3sbio acorda Therapeutics actelion alexion Pharmaceuticals alkermes alnylam Pharmaceuticals amag Pharmaceuticals amgen anika Therapeutics array Biopharma bavarian Nordic biocon biogen Idec biomarin Pharmaceuticals cangene celgene csl cubist dendreon elan emergent Biosolutions enzo Biochem galapagos genmab gilead Sciences Partnering Deals and Alliances with Big Biotech

grifols ipsen isis Pharmaceuticals lfb Group medivation morphosys nektar Therapeutics novo Nordisk nps Pharmaceuticals onyx Pharmaceuticals optimer pdl Biopharma questcor Pharmaceuticals regeneron Pharmaceuticals roche sciclone Pharmaceuticals seattle Genetics shire spectrum Pharmaceuticals swedish Orphan Biovitrum the Medicines Company ucb united Therapeutics vertex Pharmaceuticals viropharma zeltia chapter 7 – Resources appendices appendix 1 – Deal Type Definitions appendix 2 – Example Contract Document about Wildwood Ventures current Partnering current Agreements recent Titles From Currentpartnering order Form – Reports ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Partnering Deals and Alliances with Big Biotech

Add a comment

Related presentations

Related pages

Biotechnology Market Research Reports & Biotechnology ...

Biotechnology Market Research Reports & Industry Analysis. ... It discusses trends, challenges, ... Syngenta Partnering Deals and Alliances 2010 to 2016.
Read more

Worldwide Marine Biotech Market 2016 | Global Scenario ...

... market research report "Global Marine Biotech Market 2012 ... Trends, Industry Analysis, Size, Share ... Partnering Deals and Alliances with Big ...
Read more

Big Pharma | definition of Big Pharma by Medical dictionary

Looking for online definition of Big Pharma in the ... relative size based on worldwide sales, Big Pharmas new ... Partnering Deals and Alliances with ...
Read more

Pharma-Biotech Alliances - Contract Pharma

... pharma-biotech alliances are a ... our research, often stumble in the deal ... in their partnering impulses. The most lucrative deals turn ...
Read more

Pharma and Biotech Trends 2014 | Pharmaceutical Executive

... and Financial Trends Report,” recently ... Pursuit of biotech acquisitions and partnering/alliances; ... the biotech industry’s relationship with ...
Read more

Point of view - Beyond borders Matters of evidence ...

> Point of view; Beyond borders ... biotechnology industry report 2013. Point of view. Inside. ... Biotech industry has “implementation gap” around ...
Read more

EY - Beyond borders - Unlocking value - Ernst & Young

biotech industry to deal with “matters of ... 10 Beyond borders Biotechnology Industry Report 2014. 11 ... Today a signifi cant share of research activity
Read more

Global Biotechnology: Market Research Report

Global Biotechnology: Market Research Report. Global Market Research • Global Market Size • Industry ... industry statistics and industry trends, ...
Read more